Several Brands of Heart Medication Recalled

Heart problems and heart failure are two of the leading causes of death in the United States every year. As a result, pharmaceutical companies everywhere are placing a high priority on the research and development of medications that will provide relief and the ability to manage these conditions for patients.

Unfortunately, every new drug hits the market with at least some degree of risk, and that appears to have been the case with a drug that’s been known under several names, including Digitek, which was formulated by Actavis Totowa LLC, Bertek, distributed by Mylan Pharmaceuticals, Inc. and UDL, which is put out by UDL Laboratories, Inc. All of these drugs have been recalled, effective immediately, according to an announcement by the companies in conjunction with the FDA on its Web site.

The problem with these drugs is that many of the pills that were manufactured were released with twice the normal thickness in other pills, which means by result that these faulty pills can contain twice the amount of medication necessary to treat these heart conditions. When a patient inadvertently doubles the dose of this drug, he or she can suffer from digitalis toxicity, particularly in this situation when the patients have experienced renal failure. This condition can lead to vomiting, nausea, low blood pressure, dizziness and a dangerously low resting heart rate, known as bradycardia.

If you are taking any form of this medication, you need to contact your doctor immediately to find out how you should proceed. If you’ve been injured by any of these medications, contact a defective drugs attorney as soon as possible to schedule an initial consultation.

Defective Drugs, Features
Defective Drugs, digitek, FDA, heart, medication, Medicine, recall